CLINICAL_TRIALS
trial_result
· 2022-05-06
Clinical Trial Update: Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer [Phase 2]
Summary
Phase 2 trial evaluating avoidance of growth factor support during paclitaxel treatment in early stage breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Early Stage Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-05-06